Psychiatr Serv by Naslund, John A. et al.
Health Promotion for Young Adults With Serious Mental Illness
Mr. John A. Naslund, M.P.H.,
Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, Lebanon, New 
Hampshire
Dr. Kelly A. Aschbrenner, Ph.D.,
Department of Psychiatry, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire
Dr. Emily A. Scherer, Ph.D.,
Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, New 
Hampshire
Dr. Sarah I. Pratt, Ph.D., and
Department of Psychiatry, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire
Dr. Stephen J. Bartels, M.D., M.S.
Department of Psychiatry, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire
Abstract
Objective—Young adulthood represents a critical time to address elevated obesity rates and the 
risk of early mortality, particularly among people with serious mental illness. Few studies have 
assessed the benefits of lifestyle interventions targeting weight loss among these young adults. 
This study examined the impact of the 12-month In SHAPE lifestyle intervention on weight loss 
and fitness among overweight and obese young adults with serious mental illness (ages 21–30) 
compared with participants over age 30.
Methods—Data were combined from three trials of the 12-month In SHAPE program delivered 
through community mental health centers. In SHAPE includes weekly fitness trainer meetings, a 
gym membership, and nutrition education. Primary outcomes were weight loss and change in 
fitness at 12 months.
Results—Participants (N=194) had a schizophrenia spectrum disorder (53%) or a mood disorder 
(47%). The overall sample achieved significant weight loss and improved fitness; differences 
between young adults (N=29) and participants over age 30 (N=165) were not significant. An 
important finding was that 42% of young adults achieved clinically significant reductions in 
cardiovascular risk, defined as ≥5% weight loss or improved fitness (>50-m increase on the 6-
Minute Walk Test), compared with 54% of adults over age 30 (a non-significant difference 
between age groups).
Conclusions—Among persons enrolled in a lifestyle intervention, overweight and obese young 
adults experienced benefits comparable with those of adults over age 30. Young adults with 
serious mental illness face high risk of gaining weight, but a meaningful proportion of these 
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individuals can achieve clinically significant cardiovascular risk reduction, thus highlighting the 
need to promote lifestyle intervention participation in this group.
Obesity prevalence is nearly double among people with serious mental illness compared 
with the general population (1,2). Obesity is also a major contributor to cardiovascular 
disease and the resulting significantly reduced life expectancy for individuals with serious 
mental illness (3). Among people with serious mental illnesses, achieving meaningful 
reduction in cardiovascular risk requires not only significant and sustained changes to 
modifiable risk factors such as poor diet and sedentary behaviors but also overcoming 
challenges such as poverty, metabolic effects of psychoactive medications, and the impact of 
symptoms on motivation (4). Young adulthood represents a critical time to address this early 
mortality disparity because even though young adults are at greatest risk of gaining weight 
(5), they are also poised to experience lasting benefits through participation in lifestyle 
interventions by learning and adopting positive habits that they can carry forward across the 
lifespan.
Young people with serious mental illness are at risk of substantial weight gain as a result of 
mental illness onset and its consequences on life functioning and motivation, as well as the 
initiation of some antipsychotic treatments (6). Recent reports have documented the high 
prevalence of cardiometabolic risk factors among young people with first-episode 
schizophrenia spectrum disorders (7) as well as the elevated risk of cardiovascular disease 
among young people with bipolar disorder and major depressive disorder (8). A review 
found that young people with serious mental illness were more likely than young people in 
the general population to engage in poor lifestyle habits such as eating more high-fat foods 
and getting less exercise, resulting in elevated risk for long-term general medical problems, 
including cardiovascular disease and diabetes (9). However, there is limited research on the 
effect of lifestyle interventions targeting weight loss among overweight and obese adults age 
30 and under who have a serious mental illness, such as a schizophrenia spectrum disorder 
or a mood disorder.
For young adults in the general population, recent systematic reviews of lifestyle 
interventions targeting weight loss have found that the effectiveness of these efforts has been 
variable (10,11). For example, prior studies have been limited by small sample sizes, short 
intervention periods, homogeneous samples, and elevated participant attrition (12). Research 
findings also suggest that these mixed findings are partly attributable to challenges with 
engaging this age group in services, as well as to the predominant focus in prior research on 
childhood obesity or on developing interventions for middle-aged adults that may not appeal 
to the interests and unique lifestyles of young adults (12).
Among adults with serious mental illness, there is increasing evidence to support the 
effectiveness of behavioral interventions promoting fitness and healthy eating for weight loss 
(13). A series of randomized controlled trials of different lifestyle interventions has 
demonstrated the effectiveness of these programs for achieving clinically significant weight 
loss—5% or greater—or reducing cardiovascular risk for as many as half of participants 
with serious mental illness (14–17). However, across these recent studies, the impact of 
lifestyle intervention on outcomes among young adults has not been specifically examined 
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and therefore remains unclear. Prior studies have also demonstrated that behavioral 
interventions can lessen antipsychotic-induced weight gain during illness onset among 
young adults with serious mental illness who are initiating treatment (18–20). Less clear, 
however, is whether overweight or obese young adults with serious mental illness who are 
receiving stable pharmacological treatment can achieve meaningful health benefits, 
including weight loss, improved fitness, and reduction in cardiovascular risk through 
participation in a lifestyle intervention.
This study examined the impact of the 12-month In SHAPE lifestyle intervention on weight 
loss and fitness among overweight and obese young adults with serious mental illness who 
were ages 21 to 30 compared with adults over age 30. Secondary outcomes, including 
change in body mass index (BMI), waist circumference, physical activity, blood pressure, 
and lipid levels and program adherence, were also compared between the two age groups. 
The primary aim was to determine whether young adult participants with serious mental 
illness would lose weight, improve fitness, and achieve reduced cardiovascular risk at levels 
comparable with those of participants over age 30.
METHODS
This study used combined data for 194 participants with serious mental illness who received 
the In SHAPE lifestyle intervention and who completed baseline and follow-up assessments 
across three separate clinical trials. The trials included a randomized trial of 133 persons 
with serious mental illness who participated in the In SHAPE program or who had a gym 
membership from April 2007 to November 2011 in Concord, New Hampshire (14); a 
randomized trial that compared 210 persons with serious mental illness who participated in 
In SHAPE or who had a gym membership from April 2008 to May 2013 in Boston (15); and 
a trial with 122 persons with serious mental illness who participated in In SHAPE 
implemented in two community mental health centers or who received usual care in two 
additional centers from December 2009 to March 2013 in rural and urban settings in New 
Hampshire. Forty participants who completed baseline but not 12-month assessments were 
not included in this analysis. These individuals did not differ on any baseline characteristics 
from participants (N=194) who completed the study.
All participants had a serious mental illness, defined by an axis I diagnosis of schizophrenia, 
schizoaffective disorder, major depressive disorder, or bipolar disorder, and persistent 
impairment in multiple areas of functioning (such as work, school, or self-care); were age 21 
or older; had a BMI greater than 25, indicating excess weight; were on stable 
pharmacological treatment, defined as receiving the same psychiatric medications over the 
prior two months; and provided informed consent for participation. Study procedures were 
approved by Committees for the Protection of Human Subjects at Dartmouth College and 
specific to each site.
In SHAPE Program
The 12-month In SHAPE lifestyle intervention consists of a gym membership, weekly 
individual meetings with a certified fitness trainer, and instruction on healthy eating and 
nutrition. The fitness trainers are trained in tailoring individual wellness plans to the needs 
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of people with serious mental illness and complete a one-week In SHAPE training course 
consisting of instruction in motivational interviewing, fitness goal setting, nutrition, tracking 
eating and exercise, and strategies for health behavior change, such as addressing mental 
health symptoms that interfere with exercise and healthy eating. Participants obtained 
medical clearance from their primary care provider to enroll in the In SHAPE program. At 
the start of the program, the fitness trainers conducted lifestyle and fitness evaluations to 
develop personalized fitness plans for each participant and to use shared goal setting. The 
fitness trainers delivered the In SHAPE program according to a standardized protocol. For 
the program duration, fitness trainers met with participants individually each week for 60 
minutes at a local gym (YMCA). Each weekly session consisted primarily of fitness 
coaching, support, and reinforcement for exercise, followed by individualized nutrition 
education for at least 15 minutes, which emphasized a balanced diet, portion control, and 
healthy eating on a budget. To ensure fidelity to the In SHAPE program, the fitness trainers 
received weekly supervision from a health psychologist, a personal fitness trainer, and a 
registered dietitian.
Measures
Trained research interviewers collected several outcome measures at baseline and 12 
months.
Weight—Change in body weight was measured in pounds. The proportion of participants 
who achieved clinically significant weight loss of ≥5% and ≥10% was calculated because 
modest weight loss, in this range, contributes to reduction in cardiovascular risk among 
overweight and obese individuals (21,22).
Fitness—Change in fitness was assessed with the 6-Minute Walk Test (6-MWT), which 
measures the distance that an individual can walk in six minutes and is a reliable and valid 
measure of fitness (23). The proportion of participants who achieved clinically significant 
improvement in fitness, defined as an increase in distance of >50 m (about 164 feet) on the 
6-MWT, was also calculated because this improvement is associated with reduced 
cardiovascular risk (24).
Secondary obesity measures—Change in BMI, calculated as weight (kg)/height(m)2, 
and change in waist circumference, measured in inches, were reported.
Physical activity—Change in total physical activity was measured with the short-form 
International Physical Activity Questionnaire, which is a reliable and valid measure of 
physical activity among people with serious mental illness (25).
Blood pressure and lipid levels—Blood pressure was measured after participants 
completed the 6-MWT. Lipid levels were measured with the CardioChek PA Analyzer, a 
portable testing system that produces reliable values for total cholesterol, low-density 
lipoprotein, high-density lipoprotein, and triglycerides (26).
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Program adherence and retention—Adherence was measured as the number of 
sessions with the fitness trainer, out of 50 planned visits, over the 12-month intervention 
period. Study retention was defined as completion of the 12-month assessment.
Psychiatric medications—Participants’ medication use was assessed because different 
antipsychotic agents are associated with varying degrees of weight gain (27,28) and are 
known to affect ability to lose weight (2). Participants’ antipsychotic medications were 
classified as having a high (including olanzapine and clozapine), medium (risperidone), or 
low (ziprasidone) propensity for associated weight gain. Change in psychiatric medication 
use and the medication’s weight gain propensity was also examined because medication 
changes can interfere with ability to lose weight (6).
Statistical Analysis
Young adult participants (ages 21–30 years) were compared with participants over age 30 at 
baseline on demographic characteristics, obesity measures, fitness, blood pressure, lipid 
levels, and use of antipsychotic medications and on their psychiatric medications’ propensity 
to lead to weight gain. Chi-square tests were used for categorical variables, and t tests were 
used for continuous variables. Linear regression models were used to compare young adult 
participants and participants over age 30 at 12 months on continuous outcome variables, 
including primary outcomes of weight loss and fitness and secondary measures of obesity, 
physical activity, blood pressure, and lipid levels. Logistic regression models were used to 
compare the age groups on binary outcomes of whether the participant lost weight compared 
with baseline weight, achieved ≥5% weight loss, achieved ≥10% weight loss, showed 
improved fitness (>50-m increase on the 6-MWT), or achieved reduced cardiovascular risk 
(≥5% weight loss or >50-m increase on the 6-MWT) at 12 months. All regression models 
controlled for study (trial 1, 2, or 3), gender, diagnosis, race-ethnicity, and level of program 
adherence. A value of p≤.05 was considered significant. All statistical analyses were 
performed in 2015 with Stata 14.0 software.
RESULTS
Participants’ baseline characteristics are listed in Table 1. Greater proportions of young adult 
participants compared with participants over age 30 were living in supervised or supportive 
housing and were either never married or were currently married. Young adults also had 
higher levels of fitness at baseline. Other demographic characteristics, physical activity, 
smoking status, obesity measures, blood pressure and lipid levels, and use of antipsychotic 
medications did not differ between age groups at baseline.
At 12 months, the overall sample showed significant mean±SD weight loss of 4.37±19.20 
pounds (p=.002 for pre-post change) and significant improvement in fitness, as reflected by 
an increase on the 6-MWT of 59.89±228.98 feet (p=.002 for pre-post change). As 
highlighted in Table 2, there were no significant differences in outcomes between age 
groups. Although these results were not statistically significant, average weight loss and 
average BMI reduction were greater for participants over age 30 compared with young 
adults.
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Figure 1 illustrates the proportions of participants in both age groups who lost weight or who 
achieved clinically significant weight loss, improved fitness, or cardiovascular risk 
reduction. At 12 months, a greater proportion of participants over age 30 compared with 
young adults were below their baseline weight, achieved ≥5% weight loss, and showed 
improved fitness and cardiovascular risk reduction; however, none of these differences were 
statistically significant. Nearly half (45%) of young adult participants were below their 
baseline weight, 25% achieved ≥5% weight loss, 14% achieved ≥10% weight loss, and 23% 
showed clinically significant improved fitness based on a >50-m increase on the 6-MWT. 
Overall, 42% of young adult participants (compared with 54% of participants over age 30) 
showed clinically significant cardiovascular risk reduction, defined as either clinically 
significant weight loss or improved fitness (the difference was not statistically significant).
Study attrition did not differ between young adults (17%) and participants over age 30 
(17%). Adherence to the In SHAPE intervention, measured as session attendance with the 
fitness trainer out of a possible 50 sessions over the 12-month study period, was comparable 
between age groups. On average, young adults attended 27.0±14.4 sessions compared with 
29.2±13.5 sessions for participants over age 30. There were no differences in medication 
changes between the groups.
DISCUSSION
This study showed that overweight and obese young adults with serious mental illness were 
able to achieve clinically significant benefits through participation in the In SHAPE lifestyle 
intervention. At 12 months, 42% of young adult participants achieved reduction in 
cardiovascular risk, defined as ≥5% weight loss or >50-m increase on the 6-MWT. Although 
average weight loss and average BMI reduction were greater among participants over age 30 
than among young adults, these differences were not statistically significant. These findings 
expand on existing efforts to prevent weight gain among young adults with serious mental 
illness (18,19) and show promise for offering behavioral weight loss interventions to 
overweight and obese young adults in community mental health settings.
Another important finding was that neither attrition nor program adherence differed between 
age groups. This finding suggests that when young adults with serious mental illness enroll 
in a lifestyle intervention, they are as motivated as participants over age 30 to continue 
participating throughout the 12-month program. This finding is in contrast to findings of 
many prior studies of standard behavioral weight loss treatment consisting of education and 
didactic instruction in the general population, in which young adults seemed reluctant to 
participate or sustain involvement in programs over time (11).
Benefits of the In SHAPE lifestyle intervention among young adults with serious mental 
illness may be due to the emphasis on physical activity through the use of personalized 
health coaching sessions with a fitness trainer at a fitness facility located outside of the 
mental health center, which is consistent with research from the general population showing 
that young adults prefer physical activity over other methods for losing weight (29). In 
addition, research has shown that young adults respond well to emotional support for weight 
loss (29). The personal connection and support provided by the fitness trainers, who were 
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mostly young adults themselves, in the In SHAPE program may have been especially 
motivating for young adult participants with serious mental illness. For example, during 
weekly meetings with participants, the fitness trainers helped participants to develop 
individualized fitness plans, supported personal goal setting, and suggested strategies for 
overcoming mental health symptoms that interfered with healthy eating or exercise, which 
may have promoted engagement with the program (30).
The findings are promising in that 45% of young adult participants in the In SHAPE 
program were below their baseline weight at 12 months given the substantial risk of weight 
gain observed in this group. This result suggests that a lifestyle intervention delivered 
through community mental health settings may benefit both younger and older groups of 
adults. These findings could also inform continued efforts needed to target the young adult 
participants who were not successful at losing weight. Approaches that appeal specifically to 
the unique interests, perspectives, and attitudes of young adults with serious mental illness 
and that focus on sensitive issues for young people, such as self-esteem and body image 
(31), may afford added impact. For example, lifestyle interventions for young adults with 
serious mental illness could promote the benefits of adopting a healthy lifestyle to look and 
feel good while offering opportunities to socialize and have fun (12,29). Interventions 
targeting this group could also include brief education about the role of psychiatric 
medications and weight gain and provide training on how to talk to mental health providers 
about weight gain from psychotropic medications (4,6).
Emerging mobile and online technologies may also offer advantages for promoting and 
supporting weight loss and fitness among young adults with serious mental illness (4). 
Popular social media and smartphone technologies are increasingly becoming part of the 
daily lives of young people with serious mental illness (32) and may afford new 
opportunities for delivering scalable interventions capable of reaching and engaging these 
individuals at their own convenience (33). In the general population, Facebook has been 
successfully used to support weight loss among college students (34), and hybrid approaches 
using Facebook, text messaging, and smartphone applications appear promising for 
promoting engagement and retention in behavioral weight loss efforts for young adults (35). 
Recent preliminary pilot studies have highlighted the feasibility, acceptability, and potential 
effectiveness of supporting lifestyle interventions for people with serious mental illness by 
using Facebook, smartphone technologies, and wearable activity tracking devices (36,37). 
However, use of these technologies for specifically targeting and supporting behavioral 
weight loss among young adults with serious mental illness has not yet been explored.
Several limitations warrant consideration. First, all participants were receiving services at 
community mental health centers, indicating that these findings may not be generalizable to 
individuals with serious mental illness not receiving treatment. Second, nearly 70% of the 
sample was non-Hispanic white, which may limit generalizability across diverse racial or 
ethnic groups. Third, fewer young adult participants received the In SHAPE lifestyle 
intervention compared with participants over age 30. This may have increased the risk of 
type II statistical error (that is, failure to detect an effect that was present).
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As young people with mental illness grow older, they often experience a decline in physical 
function and risk developing serious medical conditions resulting from the cumulative 
impact of obesity, poor health behaviors, low socioeconomic status, and effects of living 
with mental illness on motivation and personal well-being (9). Efforts are urgently needed to 
alter this trajectory and to support young adults with serious mental illness as they develop 
behavioral patterns and habits and learn to balance their mental health symptoms with life 
demands and pursuits. Drawing from the findings presented here, future lifestyle 
interventions must specifically target weight loss and fitness among overweight and obese 
young adults with serious mental illness, so that these individuals can build confidence, learn 
necessary skills, and adopt healthy behaviors that may decrease the significant early 
mortality gap affecting this high-risk group.
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FIGURE 1. Proportion of participants achieving weight loss, fitness, and improved 
cardiovascular outcomes at 12 months, by age groupa
aThere were no significant differences between age groups at 12 months in the proportion of 
participants who were below baseline weight; achieved ≥5% or ≥10% weight loss; showed 
improved fitness, measured as >50-m increase on the 6-Minute Walk Test; or achieved 
reduced cardiovascular risk, defined as ≥5% weight loss or >50-m increase on the 6-Minute 
Walk Test.
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